Citadel Advisors
BDSI

Citadel Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Citadel Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-51,400
Closed -$159K – 15358
2021
Q4 		$159K Buy
51,400
+32,900
+178% +$111K ﹤0.01% 12198
2021
Q3 		$67K Buy
18,500
+7,700
+71% +$29K ﹤0.01% 13194
2021
Q2 		$39K Sell
10,800
-4,000
-27% -$14.1K ﹤0.01% 13427
2021
Q1 		$58K Sell
14,800
-1,300
-8% -$5.37K ﹤0.01% 12833
2020
Q4 		$68K Sell
16,100
-39,900
-71% -$154K ﹤0.01% 10442
2020
Q3 		$209K Buy
+56,000
New +$238K ﹤0.01% 8733
2020
Q2 		– Sell
-14,400
Closed -$55K – 10978
2020
Q1 		$55K Buy
14,400
+1,200
+9% +$5.9K ﹤0.01% 8994
2019
Q4 		$83K Buy
+13,200
New +$77.6K ﹤0.01% 8617
2017
Q1 		– Sell
-17,400
Closed -$30K – 8562
2016
Q4 		$30K Sell
17,400
-1,400
-7% -$2.86K ﹤0.01% 6997
2016
Q3 		$51K Buy
18,800
+400
+2% +$1.02K ﹤0.01% 6848
2016
Q2 		$43K Buy
18,400
+4,500
+32% +$12.4K ﹤0.01% 6445
2016
Q1 		$45K Buy
13,900
+11,700
+532% +$43.2K ﹤0.01% 6277
2015
Q4 		$11K Sell
2,200
-27,300
-93% -$155K ﹤0.01% 8257
2015
Q3 		$164K Buy
29,500
+7,300
+33% +$53.9K ﹤0.01% 6397
2015
Q2 		$177K Sell
22,200
-8,800
-28% -$75.6K ﹤0.01% 6477
2015
Q1 		$326K Buy
31,000
+18,300
+144% +$250K ﹤0.01% 5533
2014
Q4 		$153K Sell
12,700
-9,100
-42% -$138K ﹤0.01% 6276
2014
Q3 		$373K Buy
21,800
+15,400
+241% +$224K ﹤0.01% 5002
2014
Q2 		$77K Sell
6,400
-500
-7% -$4.74K ﹤0.01% 6438
2014
Q1 		$58K Buy
+6,900
New +$55.7K ﹤0.01% 6665

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Citadel Advisors's BDSI Position: Q1 2022 in Review

Citadel Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 84,499 shares — an estimated $262K sold.

Citadel Advisors first reported a position in BDSI in Q1 2014 and held it in 29 quarters. The position peaked at $5.85M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Citadel Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 84,499 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $262K.
  • Citadel Advisors first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 29 quarters.
  • Citadel Advisors's BioDelivery Sciences International, Inc. position peaked at $5.85M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.